Zobrazeno 1 - 10
of 336
pro vyhledávání: '"Oualla, K."'
Autor:
Rashad N, Abdulla M, Farouk M, Elkerm Y, Eid Salem S, Yahia M, Saad AS, Abdel Aziz AH, Refaat G, Awad I, ElNaggar M, Kamal K, Refky B, Abdelkhalek M, Touny A, Kassem L, Shash E, Abdelhay AA, Mahmoud BE, Oualla K, Chraiet N, AwadElkarim H Maki H, Kader YA
Publikováno v:
Cancer Management and Research, Vol Volume 14, Pp 821-842 (2022)
Noha Rashad,1 Mohamed Abdulla,2 Mohamed Farouk,3 Yasser Elkerm,4 Salem Eid Salem,5 Maha Yahia,5 Amr S Saad,6 Ahmed Hassan Abdel Aziz,6 Ghada Refaat,6 Ibrahim Awad,7 Maha ElNaggar,8 Khaled Kamal,6 Basel Refky,9 Mohamed Abdelkhalek,9 Ahmed Touny,10 Loa
Externí odkaz:
https://doaj.org/article/7f50c82cfa16419aab0207e8cc4285b1
Autor:
Cigliola A; Department of Medical Oncology, IRCCS San Raffaele Hospital, Via Olgettina 60, Milan, 20132, Italy. cigliola.antonio@hsr.it., Prakash G; Department of Uro‑Oncology, Tata Memorial Hospital, Mumbai, India., Li R; Department of GU Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Oualla K; Department of Medical Oncology, Centre Hospitalier Universitaire Hassan II, Fes, Morocco., Gupta S; Department of Hematology and Medical Oncology, Cleveland Clinic Main Campus, Cleveland, OH, USA., Kamat AM; Department of Urology Under Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chahoud J; Department of Uro‑Oncology, Tata Memorial Hospital, Mumbai, India., Necchi A; Vita-Salute San Raffaele University, Milan, Italy., Spiess PE; Department of Uro‑Oncology, Tata Memorial Hospital, Mumbai, India.
Publikováno v:
Current oncology reports [Curr Oncol Rep] 2024 Nov; Vol. 26 (11), pp. 1520.
Autor:
Cigliola A; Department of Medical Oncology, IRCCS San Raffaele Hospital, Via Olgettina 60, 20132, Milan, Italy. cigliola.antonio@hsr.it., Prakash G; Department of Uro-Oncology, Tata Memorial Hospital, Mumbai, India., Li R; Department of GU Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA., Oualla K; Department of Medical Oncology, Centre Hospitalier Universitaire Hassan II, Fes, Morocco., Gupta S; Department of Hematology and Medical Oncology, Cleveland Clinic Main Campus, Cleveland, OH, USA., Kamat AM; Department of Urology Under Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chahoud J; Department of Uro-Oncology, Tata Memorial Hospital, Mumbai, India., Necchi A; Department of Medical Oncology, IRCCS San Raffaele Hospital, Via Olgettina 60, 20132, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy., Spiess PE; Department of Uro-Oncology, Tata Memorial Hospital, Mumbai, India.
Publikováno v:
Current oncology reports [Curr Oncol Rep] 2024 Sep; Vol. 26 (9), pp. 977-990. Date of Electronic Publication: 2024 Jun 07.
Autor:
Basile G; Department of Urology, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy. basile.giuseppe@hsr.it., Necchi A; Department of Oncology, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy., Prakash G; Department of Surgical Oncology, Division of Urologic Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, India., Oualla K; Medical Oncology Department, Hassan II University Hospital, Fes, Morocco., Spiess PE; Department of Radiation Oncology, Moffitt Cancer Center, Tampa, FL, USA., Johnstone PAS; Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL, USA.
Publikováno v:
Nature reviews. Urology [Nat Rev Urol] 2024 Aug; Vol. 21 (8), pp. 453-454.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Amaadour, L., Lahrch, I., Siyouri, O., Oualla, K., Benbrahim, Z., Arifi, S., Aarab, C., El Fakir, S., Mellas, N.
Publikováno v:
Psycho-Oncologie; Mar2023, Vol. 17 Issue 1, p38-43, 6p
Publikováno v:
East African Medical Journal; Vol 95, No 9 (2018); 1951-1957
The palbociclib-letrozole combination has revolutionized the treatment of Hormone-receptor-positive Her2-negative advanced breast cancers. The aim of the inclusion of targeted agents in endocrine based therapy is to prolong hormonsensitivity and to d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=78975075580c::47ae30d8d101d1788887b942f949f351
https://www.ajol.info/index.php/eamj/article/view/192096
https://www.ajol.info/index.php/eamj/article/view/192096
Autor:
Saad ESP; Faculty of Medicine, Clinical Oncology Department, Assiut University, Assiut Governorate, Kornish Al Ibrahimeya, Asyut Second, 71515, Egypt. Erenysamwel@aun.edu.eg., Oualla K; Medical Oncology Department, Haasan II University Hospital, Sidi Mohamed Ben Abdellah University, Fes, Morocco., Talibova N; Chemotherapy Department, National Oncology Centre, Baku, Azerbaijan., Gening S; Ulyanovsk State University, Ulyanovsk, Russia., YousefYousef SG; Faculty of Medicine, Assiut University, Asyut, Egypt.
Publikováno v:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2022 Dec; Vol. 30 (12), pp. 9921-9928. Date of Electronic Publication: 2022 Oct 29.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.